General ENT News

ENT

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Hu K et al. - Epiregulin not only induced activation of both ERK1/2 and Akt, but also expression of COX-2. In addition, all these effects could be partially blocked by U0126, a specific inhibitor of mitogen-activated protein kinase kinase (MEK or MAPKK), or LY294002, a specific inhibitor of phosphatidylinositol 3-kinase (PI3K).


Today in Basic Science/Genetics...keeping you current

Pediatric cholesteatoma and variants in the gene encoding connexin 26
The Laryngoscope, 11/03/09

Audit of frequent attendees to an ENT emergency clinic
The Journal of Laryngology & Otology, 11/03/09

The nature of fibrous dysplasia
Head & Face Medicine, 11/10/09

Today in Salivary Glands...keeping you current

A phase 2 study of platinum and gemcitabine in patients with advanced salivary gland cancer
Cancer, 11/25/09

Amifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancer
Cochrane Reviews, 10/09/09

Clinicopathologic similarities between Mikulicz disease and Kuttner tumor
American Journal of Otolaryngology, 11/04/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address